Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.

@article{Zhu2008SafetyAI,
  title={Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.},
  author={Feng Zhu and Weizhong Zhou and Hongxing Pan and Lily Y. Lu and Lisya Gerez and Jos Nauta and Katinka M Giezeman and Iris A de Bruijn},
  journal={Vaccine},
  year={2008},
  volume={26 35},
  pages={4579-84}
}
The burden of influenza is well known in the elderly and at-risk patients, but also in children. Especially in those under 5 years old, influenza may cause severe morbidity and mortality. Influenza infections and complications can be reduced by vaccination. In a randomized, endpoint-blinded, parallel group trial the immunogenicity and safety was studied of two trivalent inactivated surface antigen (subunit) influenza vaccines Influvac and Agrippal in healthy children as well as in adults and… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Prevention and control of influenza . Recommendations of the Advisory Committee on Immunization Practices ( ACIP )

T Heikkinen, R Booy, M Campins
MMWR Morb Mortal Wkly Rep • 2007

Twenty years ’ experience with the safety and immunogenicity of an inactivated subunit influenza vaccine

AM Palache, J Nauta, V deRegt, IA deBruijn
Technical report of the Scientific Panel on Vaccines and Immunisation . Infant and children seasonal immunisation against influenza on a routine basis during interpandemic period . January • 2007

Combined use of the Influvac vaccine and the immunomodulator IRS19 in the prophylaxis and treatment of viral respiratory infections [ in Russian ]

A Eyubova, GM Nasrullayeva
Epidemiol Infect • 2006

Similar Papers

Loading similar papers…